Clinical trials
Glaucoma clinical trials
Below are recruiting glaucoma clinical trials, each written for real people, not researchers. We’re tracking 201 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04381611Enrolling by invitation
Study of glaucoma surgeries and laser treatments over time
This study looks at people with glaucoma or high eye pressure to understand how surgeries and laser treatments affect long-term outcomes. It may help doctors predict which treatments work best for different patients.
Lausanne, Canton of VaudAges 1–100 - NCT07780916Recruiting
Long-term results of trabectome surgery for glaucoma
This study looks at the long-term results of a specific glaucoma surgery (trabectome) done at one hospital. If you had this surgery there between 2019 and 2021, researchers want to check your eye health now to see how well it worked.
Würzburg, BavariaAges 18 years+ - NCT07619482Enrolling by invitationPhase 1/Phase 2
Insulin eye drops for glaucoma
This study tests whether insulin eye drops can help people with glaucoma by protecting the optic nerve. It is an early-stage trial that may offer a new way to manage the condition.
Palo Alto, CaliforniaAges 18–90 - NCT06682962Recruiting
Electrical stimulation for vision loss from glaucoma
This trial tests if a gentle electrical stimulation on the eye can slow or improve vision loss in people with open-angle glaucoma. It uses a device you can use at home after training.
MainzAges 40 years+ - NCT07303257Recruiting
Quality of life after glaucoma surgery: a patient-centered study
This study compares how different types of glaucoma surgery affect your daily life and well-being. If you need glaucoma surgery, you may join to help doctors understand which procedure works best from a patient's perspective.
LyonAges 18 years+ - NCT02959242Recruiting
Study of glaucoma eye pressure and risk checks
This study follows people with glaucoma, higher-than-normal eye pressure, or a suspected risk of glaucoma. It aims to better understand how eye pressure and eye findings relate to glaucoma and may guide future treatment decisions.
Dresden, SaxonyAges Any age - NCT06792422RecruitingPhase 4
Oral semaglutide for open-angle glaucoma
This trial tests if an oral medication called semaglutide can help people with open-angle glaucoma. It aims to see if it can protect the optic nerve and manage eye pressure.
Glostrup MunicipalityAges 45 years+ - NCT07228221RecruitingPhase 4
Study of iStent and iDose for moderate to severe glaucoma
This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07076303Recruiting
Laser treatment for new glaucoma patients without prior medication
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
Plymouth Meeting, PennsylvaniaAges 18 years+ - NCT05439161Recruiting
XEN gel stent compared with trabeculectomy for open-angle glaucoma
This trial compares two glaucoma operations to see which works better at lowering eye pressure and keeping the eye stable. It’s for adults with open-angle glaucoma who are eligible for either surgery and can attend follow-up visits.
SalzburgAges 18 years+ - NCT06925477Enrolling by invitation
New vs. standard laser for open-angle glaucoma
This study compares a new way of doing laser treatment for open-angle glaucoma versus the standard method. The goal is to see which approach works better at lowering eye pressure and protecting vision.
Charleston, South CarolinaAges 18 years+ - NCT07847073RecruitingPhase 4
Comparing eye drops for glaucoma and their effect on the optic nerve
This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.
Bloomington, IndianaAges 18 years+ - NCT07510087Recruiting
Glaucoma and quality of life study
This study examines how glaucoma affects day-to-day life. It asks people with any type of glaucoma to complete a questionnaire about their quality of life.
Iowa City, IowaAges 18 years+ - NCT07322965Recruiting
Citicoline and DHA supplement for glaucoma patients
This trial tests whether a dietary supplement (DHA + citicoline) can help protect vision in people with glaucoma. You may qualify if you have confirmed glaucoma in at least one eye and are between 50 and 75 years old.
Barcelona, BarcelonaAges 50–75 - NCT07243665Recruiting
Glaucoma screening with AI for diabetes patients
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
Singapore, SingaporeAges 21 years+ - NCT07220876Recruiting
VisiPlate implant for hard-to-control open-angle glaucoma
This trial tests a new device called VisiPlate that is placed in the eye to help lower pressure for people with hard-to-control open-angle glaucoma. It may be an option if standard treatments haven't worked well enough.
Glendale, ArizonaAges 45 years+ - NCT07217678RecruitingPhase 4
Eye drops and surface damage in glaucoma treatment
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
Miami, FloridaAges 18 years+ - NCT06885827Recruiting
Vitamin mix for people with glaucoma
This trial tests whether taking a daily mix of B vitamins (B6, B9, B12) and choline can help slow vision loss in people with certain types of glaucoma. You would take the vitamins or a placebo (inactive pill) for up to 2 years.
Stockholm, Stockholm CountyAges 18 years+ - NCT07073937Enrolling by invitation
Three-year results of combined microstent and canaloplasty surgery
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
Salt Lake City, UtahAges 18 years+ - NCT03870230Recruiting
Study of eye blood-flow signals in glaucoma and healthy eyes
This study compares eye blood-flow/brain-eye communication signals in people with glaucoma (or high eye pressure) versus people with normal eye tests. It may help researchers understand how glaucoma develops and progresses.
ViennaAges 18 years+ - NCT03423758Recruiting
Genetic study of eye diseases: PXF, angle-closure and open glaucoma
This study looks at blood or DNA-related factors that may explain why certain glaucoma and related eye conditions happen. It may help researchers understand risk and causes across different glaucoma types.
ViennaAges 21–105 - NCT06882356Recruiting
AI eye screening for diabetic retinopathy
This study uses an AI-based system to check for diabetic retinopathy during regular eye exams at primary care clinics. It may help catch vision problems early if you have diabetes.
Boston, MassachusettsAges 40 years+ - NCT06854198Recruiting
Glaucoma screening for at-risk Californians
This study tests whether offering eye exams at a health center helps find glaucoma early in people who are at higher risk. It may help you catch vision problems before they get worse.
Fremont, CaliforniaAges 50 years+ - NCT06822738RecruitingPhase 3
Study of XEN63 gel stent for glaucoma patients
This trial tests a new gel stent (XEN63) to lower eye pressure in adults with glaucoma. It compares two ways of putting the stent in the eye, and may help people who have not had success with other treatments.
Glendale, ArizonaAges 45 years+
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Glaucoma trials by city
Studies with a site in or near these metro areas.
Glaucoma trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for glaucoma?
- Yes. Clin2 currently lists 201 recruiting glaucoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glaucoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glaucoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.